These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 28445953)
1. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling. Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953 [TBL] [Abstract][Full Text] [Related]
2. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma. Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235 [TBL] [Abstract][Full Text] [Related]
3. NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells. Gu S; Hou P; Liu K; Niu X; Wei B; Mao F; Xu Z Chem Biol Interact; 2018 Oct; 294():40-47. PubMed ID: 30125550 [TBL] [Abstract][Full Text] [Related]
4. TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer. Yuedi D; Yuankun C; Jiaying Z; Han L; Yueqi W; Houbao L; Dexiang Z Oncotarget; 2017 Sep; 8(41):70538-70549. PubMed ID: 29050300 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells. Wang Z; Sun P; Gao C; Chen J; Li J; Chen Z; Xu M; Shao J; Zhang Y; Xie J Exp Cell Res; 2017 Aug; 357(1):1-8. PubMed ID: 28408316 [TBL] [Abstract][Full Text] [Related]
6. TRIM37 promoted the growth and migration of the pancreatic cancer cells. Jiang J; Tian S; Yu C; Chen M; Sun C Tumour Biol; 2016 Feb; 37(2):2629-34. PubMed ID: 26395261 [TBL] [Abstract][Full Text] [Related]
7. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells. Sun P; Xiong H; Kim TH; Ren B; Zhang Z Mol Pharmacol; 2006 Feb; 69(2):520-31. PubMed ID: 16291872 [TBL] [Abstract][Full Text] [Related]
8. Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells. Dai Y; Wang M; Wu H; Xiao M; Liu H; Zhang D Oncotarget; 2017 Feb; 8(6):9783-9793. PubMed ID: 28039460 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3. Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100 [TBL] [Abstract][Full Text] [Related]
10. CDK7 activated beta-catenin/TCF signaling in hepatocellular carcinoma. Duan J; He Y; Fu X; Deng Y; Zheng M; Lu D Exp Cell Res; 2018 Sep; 370(2):461-467. PubMed ID: 29981747 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of SRPK1 in non-small cell lung cancer promotes the growth and migration of cancer cells. Liu H; Hu X; Zhu Y; Jiang G; Chen S Tumour Biol; 2016 Jun; 37(6):7287-93. PubMed ID: 26666824 [TBL] [Abstract][Full Text] [Related]
12. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling. Liu L; Wu J; Wang S; Luo X; Du Y; Huang D; Gu D; Zhang F Exp Cell Res; 2017 Sep; 358(2):209-216. PubMed ID: 28648520 [TBL] [Abstract][Full Text] [Related]
13. Serum and glucocorticoid kinase 1 promoted the growth and migration of non-small cell lung cancer cells. Xiaobo Y; Qiang L; Xiong Q; Zheng R; Jianhua Z; Zhifeng L; Yijiang S; Zheng J Gene; 2016 Jan; 576(1 Pt 2):339-46. PubMed ID: 26548813 [TBL] [Abstract][Full Text] [Related]
14. DLX1, a binding protein of beta-catenin, promoted the growth and migration of prostate cancer cells. Liang M; Sun Y; Yang HL; Zhang B; Wen J; Shi BK Exp Cell Res; 2018 Feb; 363(1):26-32. PubMed ID: 29317218 [TBL] [Abstract][Full Text] [Related]
15. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors. Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061 [TBL] [Abstract][Full Text] [Related]
16. Cilia loss sensitizes cells to transformation by activating the mevalonate pathway. Deng YZ; Cai Z; Shi S; Jiang H; Shang YR; Ma N; Wang JJ; Guan DX; Chen TW; Rong YF; Qian ZY; Zhang EB; Feng D; Zhou QL; Du YN; Liu DP; Huang XX; Liu LM; Chin E; Li DS; Wang XF; Zhang XL; Xie D J Exp Med; 2018 Jan; 215(1):177-195. PubMed ID: 29237705 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of mediator MED23 in non-small-cell lung cancer promotes the growth, migration, and metastasis of cancer cells. Shi J; Liu H; Yao F; Zhong C; Zhao H Tumour Biol; 2014 Dec; 35(12):12005-13. PubMed ID: 25273169 [TBL] [Abstract][Full Text] [Related]
18. UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity. Zhong J; Zhao M; Ma Y; Luo Q; Liu J; Wang J; Yuan X; Sang J; Huang C Int J Mol Med; 2012 Aug; 30(2):430-6. PubMed ID: 22641175 [TBL] [Abstract][Full Text] [Related]
19. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling. Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395 [TBL] [Abstract][Full Text] [Related]
20. Streptonigrin inhibits β-Catenin/Tcf signaling and shows cytotoxicity in β-catenin-activated cells. Park S; Chun S Biochim Biophys Acta; 2011 Dec; 1810(12):1340-5. PubMed ID: 21763403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]